Medicine Innovation Program Grant: Dr. Mannstadt Interview
Interview with 2015 Medicine Innovation Program grant winners: Long-Acting PTH for Treatment of Patients with Hypoparathyroidism.
Michael Mannstadt, MD is Chief of the Endocrine Unit at Massachusetts General Hospital and Associate Professor in Medicine, Harvard Medical School, both in Boston. He is a Board Certified Endocrinologist.
He earned his MD from Jena University in Germany. He completed his residency in Medicine, Fellowship in Endocrinology and Chief Residency in Medicine, all at Massachusetts General Hospital and Harvard Medical School, Boston.
Dr. Mannstadt's clinical interest focuses on disorders of mineral metabolism and bone diseases. His research concentrates on the basic and translational aspects of parathyroid hormone with a particular interest in hypoparathyroidism.
Departments, Centers, & Programs:
Clinical Interests:
Treats:
Mass General Endocrinology: Thyroid Associates
55 Fruit St.
Wang Ambulatory Care Center
Suite 730S
Boston, MA 02114
Phone: 617-726-8720
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
The Adolescent and Young Adult Cancer Program was created to optimize the care, outcomes, and experiences of adolescent and young adult patients.
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2024-2025.
Interview with 2015 Medicine Innovation Program grant winners: Long-Acting PTH for Treatment of Patients with Hypoparathyroidism.